ARZC-001 / Artizan Biosci - LARVOL DELTA

Artizan Biosciences Selects Lead Product Candidate for Inflammatory Bowel Disease Therapeutic Development Program (GlobeNewswire) - "Artizan Biosciences, Inc...announced the selection of its lead product candidate, ARZC-001, for the treatment of inflammatory bowel disease ('IBD')...'we are excited to advance ARZC-001 into the clinic to help patients with these devastating diseases and look forward to filing an Investigational New Drug application by the end of 2022.'"

IND • Inflammatory Bowel Disease